HTFL - שולי רווח נקי ממכירות HeartFlow Inc

HTFL (HeartFlow) - סמל מסחרי של החברה

Net profit per unit of revenue demonstrates current efficiency, with the latest reading standing at -33.10. Growth is driven by FDA approval of FFRct analysis and the adoption of the company's software by clinics. The high precision of its cloud AI allows Heartflow Inc (HTFL) to maintain premium pricing power. Dominance in the 3D blood flow modeling niche and active R&D efforts ensure the technological leadership of Heartflow Inc (HTFL) in cardiology.

רווחיות מכירות נקייה HeartFlow Medical (HTFL): לתקופה 09.08.2025 - 19.11.2026

HeartFlow Medical (HTFL) - פילוחי מדדים ודוחות פיננסיים

- מחיר מניה וקונצנזוס הערכת שווי:
הערכת שווי פונדמנטלית של החברה:HeartFlow Corp - HTFL
סחורת הדגל של HeartFlow Corp

The global diversification of the Heartflow Inc (HTFL) AI platform across medicine and pharmacology makes revenue efficiency analysis critical for assessing business sustainability. This indicator compares operating profit to market capitalization, determining the actual net income percentage during interim reporting periods. By analyzing actual net profit margins, an investor can differentiate fundamentally undervalued assets from overheated securities, thereby minimizing the risk of capital freeze.